TrialJournal of patient-reported outcomes2024

Re-examining the factor structure of the Insomnia Severity Index (ISI) and defining the meaningful within-individual change (MWIC) for subjects with insomnia disorder in two phase III clinical trials of the efficacy of lemborexant.

William R Lenderking et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.